Immune checkpoint inhibitors (ICIs) are widely used in cancer therapy. They boost the immune system's ability to destroy cancer cells but lead to immune-related adverse events (irAEs). ICIs-related hypophysitis (IRH) is one of the most significant endocrine i... ...

请注册登录后继续浏览